Results 131 to 140 of about 68,817 (283)

Human hypoxia models in aerospace medicine: Potential applications for human pharmacological research

British Journal of Clinical Pharmacology, EarlyView.
Aerospace medicine required controlled terrestrial models to investigate influences of altered atmosphere conditions, such as hypoxia, on human health and performance. These models could potentially be expanded to encompass disease conditions or treatment targets regulated through hypoxia or hypercapnia.
Titiaan E. Post, Cayla Denney, Adam Cohen, Jens Jordan, Ulrich Limper   +4 more
wiley   +1 more source

PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice [PDF]

, 2000
Michaela R. Hoffmeyer, Rosario Scalia, Chris Ross, Steven P. Jones, David J. Lefer   +4 more
openalex   +1 more source

Robot‐assisted vs open kidney transplantation from deceased donors

BJU International, EarlyView.
Objectives To test the hypothesis that the type of surgical approach, robot‐assisted kidney transplantation (RAKT) vs open kidney transplantation (OKT), impacts intra‐operative and postoperative surgical outcomes of patients receiving kidney transplantation from deceased donors.
Luca Afferi, Angelo Territo, Alessio Pecoraro, Lorenzo Masieri, Milla Ortved, Julia Abildgaard Dagnæs‐Hansen, Begonya Etcheverry, Andrea Gallioli, Donato Cannoletta, Joris Vangeneugden, Jeremy Mercier, Thomas Prudhomme, Isacco Donnini, Antonino Vazzana, Malene Rohrsted, Francesc Vigués, Nicolas Doumerc, Karel Decaestecker, Joan Palou, Riccardo Campi, Sergio Serni, Andreas Roder, Alberto Breda   +22 more
wiley   +1 more source

Prevention of Myocardial Reperfusion Injury in Experimental Coronary Revascularization Following Ischemic Arrest by a Novel Antiinflammatory Drug, ONO-3144

, 1990
Yutaka Kimura, Jaisimha Iyengar, Richard M. Engelman, Dipak K. Das   +3 more
openalex   +1 more source

Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion [PDF]

, 2000
Jason M. Budde, Daniel A. Velez, Zhi-Qing Zhao, Kenneth L. Clark, Cullen D. Morris, Satoshi Muraki, Robert A. Guyton, Jakob Vinten-Johansen   +7 more
openalex   +1 more source

Crucial Role of Endogenous Interleukin-10 Production in Myocardial Ischemia/Reperfusion Injury [PDF]

, 2000
Zequan Yang, Basilia Zingarelli, Csaba Szabó   +2 more
openalex   +1 more source

Platelet Membrane Nanocarriers Cascade Targeting Delivery System to Improve Myocardial Remodeling Post Myocardial Ischemia–Reperfusion Injury

Advanced Science
Although treatments for myocardial infarction have advanced significantly, the global mortality due to ischemia and subsequent reperfusion injury remains high. Here, a platelet (PLT) membrane nanocarrier (PL720) that encapsulates L‐arginine and FTY720 to
Xuan Xu, Mingxi Li, Fuchao Yu, Qin Wei, Yang Liu, Jiayi Tong, Fang Yang   +6 more
doaj   +1 more source

Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury [PDF]

, 2000
Mihaela Mocanu, Gary F. Baxter, Derek M. Yellon   +2 more
openalex   +1 more source

Matrix metalloproteinase inhibition protects against junctophilin‐2 proteolysis during doxorubicin‐induced cardiotoxicity

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Treatment of cancer patients with anthracyclines is known to cause dose‐dependent cardiotoxicity through several mechanisms including enhanced oxidative stress, ultimately resulting in defective excitation–contraction coupling.
Wesam Bassiouni, Brandon Y. H. Chan, Andrej Roczkowsky, Joshua W. Kranrod, Zabed Mahmud, Joseph O. Primeau, Woo Jung Cho, Howard S. Young, John M. Seubert, Richard Schulz   +9 more
wiley   +1 more source

Reduction in reperfusion injury by blood-free reperfusion after experimental myocardial infarction

, 1990
Gary L. Schaer, Steven P. Karas, Edward C. Santoian, Craig Gold, Marc S. Visner, Renu Virmani   +5 more
openalex   +1 more source